Contact
Email: | |
---|---|
Phone: | +420 54949 8630 |
Research group: | CF: Genomics Core Facility, Medical Genomics - Šárka Pospíšilová |
Workplace: |
11. Mar. 2021
Rychlejší než PCR a přesnější než antigenní. Brněnští vědci vyvinuli LAMP test a jednají s výrobci
Čeští vědci vyvinuli nové testy proti koronaviru. Měly by zvládnout rozpoznat virus spolehlivěji než antigenní testy s výsledkem do hodiny a bez…
19. Aug. 2020
CEITEC Awarded By the Mayor of Brno for Help During the Pandemic
Solidarity and immediacy. This was, among other things, highlighted by the mayor of the city of Brno, Markéta Vaňková, at the closing ceremony of the…
22. June 2020
European Mark in the Coronavirus Fight
The coronavirus pandemic has clearly shown the enormous importance of research organizations, their infrastructures and, of course,…
21. May 2020
CEITEC Scientists Are Developing Faster Tests for COVID-19 Disease
Experts from CEITEC Masaryk University (MU) want to expand the testing possibilities and simplify the testing process for the presence of the SARS…
Publications that are part of the Web of Science database, possibly also other publications chosen by authors.
2017
- Brhelova, E; Antonova, M; Pardy, F; Kocmanova, I; Mayer, J; Racil, Z; Lengerova, M, 2017: Investigation of next-generation sequencing data of Klebsiella pneumoniae using web-based tools. JOURNAL OF MEDICAL MICROBIOLOGY 66(11), p. 1673 - 1683, doi: 10.1099/jmm.0.000624
2015
- Malcikova, J; Stano-Kozubik, K; Tichy, B; Kantorova, B; Pavlova, S; Tom, N; Radova, L; Smardova, J; Pardy, F; Doubek, M; Brychtova, Y; Mraz, M; Plevova, K; Diviskova, E; Oltova, A; Mayer, J; Pospisilova, S; Trbusek, M, 2015: Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia. LEUKEMIA 29(4), p. 877 - 885, doi: 10.1038/leu.2014.297
- Tom, N; Malcikova, J; Radova, L; Kantorova, B; Pardy, F; Pavlova, S; Pal, K; Mraz, M; Tichy, B; Doubek, M; Brychtova, Y; Plevova, K; Mayer, J; Trbusek, M; Pospisilova, S, 2015: MUTATIONS IN THE TP53 GENE SHOW FEATURES OF SOMATIC HYPERMUTATION PROCESS WITH PROMINENT DIFFERENCE BETWEEN IGHV MUTATED AND UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA. HAEMATOLOGICA 100, p. 224 - 225
- Creating synergies between research infrastructures to stimulate innovation in the cross-border region (ATCZ40), Ministerstvo pro místní rozvoj ČR, 2016 - 2020
- Národní centrum lékařské genomiky (LM2015091), Ministerstvo školství, mládeže a tělovýchovy ČR, 2016 - 2019
- NCLG - Národní centrum lékařské genomiky - modernizace infrastruktury a výzkum genetické variability populace (CZ.02.1.01/0.0/0.0/16_013/0001634), Ministerstvo školství, mládeže a tělovýchovy ČR, 2017 - 2019
- Expression and function of activation-induced cytidine deaminase splice variants in normal B cell physiology and chronic lymphocytic leukemia (3SGA5792), Jihomoravský kraj, 2013 - 2016
- Functional and structural changes of microRNAs in lymphoproliferative malignancies and their impact on prognosis and prediction of therapy response (NT11218), Ministry of Health - Ministry of Health´s Departmental Research and Development Programme III (2010-2015), 2010 - 2015
- NGS-PTL - Next Generation Sequencing platform for targeted Personalized Therapy of Leukemia (306242), Evropská unie, 2012 - 2015
- SuPReMMe - Podpora profesního růstu a mezinárodní integrace výzkumných týmů v oblasti molekulární medicíny (CZ.1.07/2.3.00/20.0045), Ministerstvo školství, mládeže a tělovýchovy ČR, 2011 - 2014
- Real-time PCR soupravy pro diagnostiku v onkologii (FR-TI2/254), Ministerstvo průmyslu a obchodu ČR, 2010 - 2013
- Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies (MSM0021622430), Ministerstvo školství, mládeže a tělovýchovy ČR, 2007 - 2013
- Involvement of nuclear HMGB proteins in sensitizing of human cells to anticancer drugs inhibiting DNA topoizomerases (GAP301/10/0590), Czech Science Foundation - Standard Grants, 2010 - 2012
- Analysis of changes in genome and its expression in chronic lymphocytic leukemia patients during the disease development (NS10439), Ministry of Health - Departmental Programme of Research and Development (2008-2011), 2009 - 2011